Table 2 Circulating levels of oestradiol, follicle-stimulating hormone and luteinizing hormone at baseline and after 12 months, and change from baseline to 12 months by treatment group
Isoflavone group (n= 56) | Placebo (n = 61)a | ||||||
|---|---|---|---|---|---|---|---|
Baseline | 12 months | Change | Baseline | 12 months | Change | P for changeb | |
Oestradiol (pmol/l) | 22.6 ± 12.2 | 36.6 ± 65.0 | 14.0 ± 64.7 | 22.6 ± 13.3 | 21.6 ± 9.0 | -0.9 ± 11.5 | 0.49 |
FSH (IU/l) | 76.2 ± 21.5 | 72.0 ± 23.5 | -4.2 ± 12.9 | 77.6 ± 25.1 | 74.5 ± 23.9 | -2.9 ± 13.0 | 0.83 |
LH (IU/l) | 43.9 ± 15.4 | 39.9 ± 14.6 | -4.0 ± 11.7 | 45.5 ± 16.0 | 41.2 ± 12.0 | -4.2 ± 9.2 | 0.71 |